Defended Upsher-Smith in Hatch-Waxman Litigation Involving Isotretinoin Capsules | Patent Litigation Case Results | Robins Kaplan LLP Law Firm

Allowing for Commercial Launch Three Months before Orange Book-Listed Patents’ Expiration Date

September 4, 2020

Galephar Pharmaceutical et al. v. Upsher-Smith Laboratories, LLC

Robins Kaplan LLP served as lead counsel to Upsher-Smith in Hatch-Waxman patent litigation in the District of New Jersey brought by Galephar Pharmaceutical Research, Inc., Cipher Pharmaceuticals Inc., and Sun Pharmaceutical Industries, Inc. asserting infringement of five patents covering Absorica® (Isotretinoin) Capsules.

The case settled on September 4, 2020. Upsher-Smith announced the launch of its Isotretinoin Capsules on June 25, 2021, nearly three months before the Orange Book-listed patents’ expiration date.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Disclaimer

Jake M. Holdreith

Partner

Member of Executive Board

Christopher A. Pinahs

Partner

Emily J. Tremblay

Associate

Charlie C. Gokey

Partner

Ellen Levish

Associate

Pronouns: she/her

Intellectual Property and Technology Litigation Name, Image, and Likeness (NIL) Disputes

Intellectual Property and Technology Litigation Patent Litigation Hatch-Waxman Litigation

Intellectual Property and Technology Litigation Business Litigation Trade Secret Litigation

Intellectual Property and Technology Litigation Patent Litigation

Intellectual Property and Technology Litigation Patent Litigation Trade Secret Litigation

Hatch-Waxman Litigation

Intellectual Property and Technology Litigation Patent Litigation

Intellectual Property and Technology Litigation Patent Litigation

Intellectual Property and Technology Litigation Patent Litigation Patent Office Trials

Intellectual Property and Technology Litigation Trade Secret Litigation

Hatch-Waxman Litigation Intellectual Property and Technology Litigation

Intellectual Property and Technology Litigation Trade Secret Litigation

Intellectual Property and Technology Litigation Patent Litigation

Hatch-Waxman Litigation Intellectual Property and Technology Litigation

Business Litigation Intellectual Property and Technology Litigation Trade Secret Litigation

Back to Top

Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.

If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.

By accepting these terms, you are confirming that you have read and understood this important notice.